Incidence of treatment-emergent adverse events and serious adverse events. 6 months [clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791]

Incidence of treatment-emergent adverse events and serious adverse events. 6 months [clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791]

35mg/m^2 infusion time is 3.5 minutes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791
A Safety Study of ABI-007 for In-Stent Restenosis [clinicaltrials:NCT00093223]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Incidence of treatment-emergent adverse events and serious adverse events. 6 months [clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791]

35mg/m^2 infusion time is 3.5 minutes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791
Bio2RDF identifier
1d51dfd2ca5eebce27efbc6a1c82d791
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791
measure [clinicaltrials_vocabulary:measure]
Incidence of treatment-emergent adverse events and serious adverse events.
time frame [clinicaltrials_vocabulary:time-frame]
description
35mg/m^2 infusion time is 3.5 minutes
identifier
clinicaltrials_resource:1d51dfd2ca5eebce27efbc6a1c82d791
title
Incidence of treatment-emergent adverse events and serious adverse events. 6 months
@en
inDataset
type
label
Incidence of treatment-emergen ...... 1dfd2ca5eebce27efbc6a1c82d791]
@en